TRIUMPH-1: The Pivotal General Obesity Trial (May 2026) TRIUMPH-1 is the most important trial in the program for FDA purposes
People in the combination SGLT2i with dulaglutide group had 0.63%, 0.52%, and 0.58% greater reductions in HbA 1c from baseline at 6, 12, and 18 months, respectively
And for anyone, diabetic or not, the drugs slow down the transit of food through the stomach, prolonging a feeling of fullness as well as acting on GLP-1 receptors in the brain to tamp down appetite, promoting weight loss in a different way
Scientific References Frequently Asked Questions What should I do if I miss my Ozempic dose
Legislation PSM was among organizations that gave testimony that led Colorados House Health & Human Services committee to indefinitely postpone Colorado House Bill 1056
Stick to the recommended treatment plan, stay engaged, eat healthy meals, and move your body regularly